Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ELV
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Ratnakar Lavu EVP & Chief Digital Info Ofr | ELV Elevance Health, Inc. | Sale | 1,300 | $440.00 | $572.0K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 273 | $447.19 | $122.1K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 827 | $446.05 | $368.9K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 160 | $444.85 | $71.2K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 440 | $443.81 | $195.3K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 480 | $442.61 | $212.5K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 2,343 | $441.34 | $1.0M Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 1,720 | $440.44 | $757.6K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 1,160 | $439.25 | $509.5K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 240 | $438.22 | $105.2K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 560 | $437.07 | $244.8K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 1,660 | $436.20 | $724.1K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 321 | $435.25 | $139.7K Sale | Form 4 ↗ |
| Oct 22, 2026 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 400 | $434.00 | $173.6K Sale | Form 4 ↗ |
| Jul 17, 2026 | Gail Boudreaux President and CEO, Director | ELV Elevance Health, Inc. | Buy | 2,045 | $368.25 | $753.1K Buy | Form 4 ↗ |
| Jul 17, 2026 | Gail Boudreaux President and CEO, Director | ELV Elevance Health, Inc. | Buy | 680 | $366.41 | $249.2K Buy | Form 4 ↗ |
| Jul 17, 2026 | Ramiro G. Peru Director | ELV Elevance Health, Inc. | Buy | 1,000 | $366.05 | $366.1K Buy | Form 4 ↗ |
| Jun 12, 2026 | Ronald W. Penczek CAO & Controller | ELV Elevance Health, Inc. | Sale | 369 | $403.16 | $148.8K Sale | Form 4 ↗ |
| Jun 11, 2026 | Robert L. Dixon Jr. Director | ELV Elevance Health, Inc. | Sale | 151 | $401.77 | $60.7K Sale | Form 4 ↗ |
| May 19, 2026 | Ronald W. Penczek CAO & Controller | ELV Elevance Health, Inc. | Sale | 1,531 | $403.13 | $617.2K Sale | Form 4 ↗ |
| Mar 12, 2026 | Amy W. Schulman Director | ELV Elevance Health, Inc. | Sale | 26 | $287.50 | $7,475 Sale | Form 4 ↗ |
| Mar 6, 2026 | Charles Morgan Kendrick Jr. EVP & President, Commercial | ELV Elevance Health, Inc. | Sale | 3,196 | $284.92 | $910.6K Sale | Form 4 ↗ |
| Mar 5, 2026 | Steven H. Collis Director | ELV Elevance Health, Inc. | Buy | 3,000 | $289.84 | $869.5K Buy | Form 4 ↗ |
| Aug 19, 2025 | Susan D. DeVore Director | ELV Elevance Health, Inc. | Buy | 1,200 | $312.15 | $374.6K Buy | Form 4 ↗ |
| Jul 18, 2025 | Gail Boudreaux President and CEO, Director | ELV Elevance Health, Inc. | Buy | 1,050 | $287.96 | $302.4K Buy | Form 4 ↗ |
| Jul 18, 2025 | Gail Boudreaux President and CEO, Director | ELV Elevance Health, Inc. | Buy | 5,116 | $287.12 | $1.5M Buy | Form 4 ↗ |
| Jul 18, 2025 | Gail Boudreaux President and CEO, Director | ELV Elevance Health, Inc. | Buy | 2,334 | $286.07 | $667.7K Buy | Form 4 ↗ |
| Apr 24, 2025 | Mark Kaye EVP & CFO | ELV Elevance Health, Inc. | Sale | 4,588 | $424.82 | $1.9M Sale | Form 4 ↗ |
| Mar 10, 2025 | Ronald W. Penczek CAO & Controller | ELV Elevance Health, Inc. | Sale | 443 | $415.13 | $183.9K Sale | Form 4 ↗ |
| Mar 5, 2025 | Charles Morgan Kendrick Jr. EVP & President, Commercial | ELV Elevance Health, Inc. | Sale | 3,504 | $396.30 | $1.4M Sale | Form 4 ↗ |
| Oct 18, 2024 | Charles Morgan Kendrick Jr. EVP & President, Commercial | ELV Elevance Health, Inc. | Sale | 7,417 | $432.14 | $3.2M Sale | Form 4 ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:03 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances